GlassScriptPhysician profile
Mubarik B Mohamed
NPI 1669051835
$4,193.35
in general payments reported to CMS, 2019-2025
10 companies · $780 in 2025
The $780 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,195 · 2024: $1,219 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,950 · Travel and Lodging: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,950.06 |
| Travel and Lodging | $1,243.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,682.37 | 2023 | Stellaris Elite, Trulign Iol, Envista Mx60 Iol |
| Alcon Vision LLC | $1,131.94 | 2023-2025 | Clareon, Hydrus Microstent, Centurion |
| Johnson & Johnson Surgical Vision, INC. | $333.49 | 2023-2025 | Meibomian Gland Evaluator, Lipiflow System Activator II (Disposable, Lipiview Ocular Surface Interferometer |
| New World Medical,INC. | $325.27 | 2023-2024 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Glaukos Corporation | $240.57 | 2023-2025 | Istent Trabecular Micro-Bypass System Model Is3, Istent Infinite, Idosetr |
| Sight Sciences, INC. | $179.80 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Biotissue Holdings INC. | $127.50 | 2025 | |
| Abbvie INC. | $72.65 | 2023-2025 | |
| Genentech USA, INC. | $62.53 | 2023-2024 | Vabysmo |
| Apellis Pharmaceuticals, INC. | $37.23 | 2024 | Syfovre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mubarik Mohamed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.